NCT02401113

Brief Summary

This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of Ursolic Acid of Loquat Extract for treatment of muscle function improvement with relatively health adults. 54 subjects received 500 mg of Loquat Extract per day or a placebo for 12 weeks.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Nov 2014

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 27, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

November 3, 2015

Status Verified

October 1, 2015

Enrollment Period

3 months

First QC Date

March 24, 2015

Last Update Submit

October 30, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • quadriceps muscle function

    12weeks

Secondary Outcomes (2)

  • ASM(appendicular skeletal mass) marker

    12weeks

  • Short Physical Performance Battery, SPPB

    12weeks

Study Arms (2)

UA group

EXPERIMENTAL

UA group who takes Ursolic acid of Loquat Extract , 500 mg/ day during 12 weeks for treatment of muscle function improvement with relatively health adults

Dietary Supplement: UA group

placebo group

PLACEBO COMPARATOR

placebo group who takes a placebo, 500 mg/day for 12 weeks

Dietary Supplement: UA group

Interventions

UA groupDIETARY_SUPPLEMENT

Ursolic Acid of Loquat Extract, 500mg/ day during 12 weeks

UA groupplacebo group

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI 18.5-30KG/M2

You may not qualify if:

  • \> SERUM creatinine 1.2mg/dL
  • \> AST or ALT 60IU/L
  • DM Patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Prissadova N, Bozov P, Marinkov K, Badakov H, Kristev A. Effects of ursolic acid on contractile activity of gastric smooth muscles. Nat Prod Commun. 2015 Apr;10(4):565-6.

  • Cho YH, Lee SY, Kim CM, Kim ND, Choe S, Lee CH, Shin JH. Effect of Loquat Leaf Extract on Muscle Strength, Muscle Mass, and Muscle Function in Healthy Adults: A Randomized, Double-Blinded, and Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2016;2016:4301621. doi: 10.1155/2016/4301621. Epub 2016 Nov 24.

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • SANG YEOUP Lee, Pf.

    Pusan National University Yangsan Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
family medicine

Study Record Dates

First Submitted

March 24, 2015

First Posted

March 27, 2015

Study Start

November 1, 2014

Primary Completion

February 1, 2015

Study Completion

October 1, 2015

Last Updated

November 3, 2015

Record last verified: 2015-10